Cancer Stat Facts: Hodgkin Lymphoma

Statistics at a GlanceShow More

At a Glance

  • Estimated New Cases in 2017 8,260
  • % of All New Cancer Cases0.5%
  • Estimated Deaths in 2017 1,070
  • % of All
    Cancer Deaths

Percent Surviving
5 Years

86.4% 2007-2013

Number of New Cases and Deaths per 100,000: The number of new cases of Hodgkin lymphoma was 2.6 per 100,000 men and women per year. The number of deaths was 0.3 per 100,000 men and women per year. These rates are age-adjusted and based on 2010-2014 cases and deaths.

Lifetime Risk of Developing Cancer: Approximately 0.2 percent of men and women will be diagnosed with Hodgkin lymphoma at some point during their lifetime, based on 2012-2014 data.

Prevalence of This Cancer: In 2014, there were an estimated 204,065 people living with Hodgkin lymphoma in the United States.

Survival StatisticsShow More

How Many People Survive 5 Years Or More after Being Diagnosed with Hodgkin Lymphoma?

Relative survival statistics compare the survival of patients diagnosed with cancer with the survival of people in the general population who are the same age, race, and sex and who have not been diagnosed with cancer. Because survival statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. No two patients are entirely alike, and treatment and responses to treatment can vary greatly.


Percent Surviving
5 Years


Based on data from SEER 18 2007-2013. Gray figures represent those who have died from Hodgkin lymphoma. Green figures represent those who have survived 5 years or more.

Additional Information

Cancer stage at diagnosis, which refers to extent of a cancer in the body, determines treatment options and has a strong influence on the length of survival. In general, if the cancer is found only in the part of the body where it started it is localized (sometimes referred to as stage 1). If it has spread to a different part of the body, the stage is regional or distant. For Hodgkin lymphoma, 15.6% are diagnosed at the local stage. The 5-year survival for localized Hodgkin lymphoma is 92.2%.

Percent of Cases & 5-Year Relative Survival by Stage at Diagnosis: Hodgkin Lymphoma
Percent of Cases by Stage
  • Localized (16%)
    Confined to Primary Site
  • Regional (40%)
    Spread to Regional Lymph Nodes
  • Distant (40%)
    Cancer Has Metastasized
  • Unknown (4%)
16% localized; 40% regional; 40% distant; 4% unknown
5-Year Relative Survival
92.2% localized; 93.1% regional; 77.9% distant; 82.1% unstaged

SEER 18 2007-2013, All Races, Both Sexes by SEER Summary Stage 2000

Additional Information

Number of New Cases and DeathsShow More

How Common Is This Cancer?

Compared to other cancers, Hodgkin lymphoma is rare.

Common Types of Cancer Estimated New
Cases 2017
Deaths 2017
1. Breast Cancer (Female) 252,710 40,610
2. Lung and Bronchus Cancer 222,500 155,870
3. Prostate Cancer 161,360 26,730
4. Colorectal Cancer 135,430 50,260
5. Melanoma of the Skin 87,110 9,730
6. Bladder Cancer 79,030 16,870
7. Non-Hodgkin Lymphoma 72,240 20,140
8. Kidney and Renal Pelvis Cancer 63,990 14,400
9. Leukemia 62,130 24,500
10. Uterine Cancer 61,380 10,920
- - -
25. Hodgkin Lymphoma 8,260 1,070

Hodgkin lymphoma represents 0.5% of all new cancer cases in the U.S.


In 2017, it is estimated that there will be 8,260 new cases of Hodgkin lymphoma and an estimated 1,070 people will die of this disease.

Hodgkin lymphoma is more common among young adults and among men than women. It can occur in both adults and children; however, treatment for adults may be different than treatment for children. Hodgkin lymphoma may also occur in patients who have acquired immunodeficiency syndrome (AIDS); these patients require special treatment. The number of new cases of Hodgkin lymphoma was 2.6 per 100,000 men and women per year based on 2010-2014 cases.

Number of New Cases per 100,000 Persons by Race/Ethnicity & Sex: Hodgkin Lymphoma
  • Male 2.9All RacesFemale 2.3
  • Male 3.1WhiteFemale 2.4
  • Male 3.1BlackFemale 2.2
  • Male 1.6Asian /
    Pacific Islander
    Female 1.1
  • Male 1.4American Indian /
    Alaska Native
    Female 1.3
  • Male 2.6HispanicFemale 1.9
  • Male 3.1Non-HispanicFemale 2.4

SEER 18 2010-2014, Age-Adjusted

Percent of New Cases by Age Group: Hodgkin Lymphoma
12.2% under 20; 31.3% 20-34; 14.0% 35-44; 12.7% 45-54; 11.8% 55-64; 9.0% 65-74; 6.6% 75-84; 2.3% 85 and older

Hodgkin lymphoma is most frequently diagnosed among people aged 20-34.

Median Age
At Diagnosis


SEER 18 2010-2014, All Races, Both Sexes

The number of deaths was 0.3 per 100,000 men and women per year based on 2010-2014 deaths.

Number of Deaths per 100,000 Persons by Race/Ethnicity & Sex: Hodgkin Lymphoma
  • Male 0.4All RacesFemale 0.3
  • Male 0.4WhiteFemale 0.3
  • Male 0.4BlackFemale 0.2
  • Male 0.2Asian /
    Pacific Islander
    Female 0.1
  • Not Shown, <16 casesAmerican Indian /
    Alaska Native
    Not Shown, <16 cases
  • Male 0.5HispanicFemale 0.3
  • Male 0.4Non-HispanicFemale 0.3

U.S. 2010-2014, Age-Adjusted

Percent of Deaths by Age Group: Hodgkin Lymphoma
1.0% under 20; 11.5% 20-34; 8.4% 35-44; 11.1% 45-54; 15.6% 55-64; 19.6% 65-74; 21.5% 75-84; 11.3% 85 and older

The percent of Hodgkin lymphoma deaths is highest among people aged 75-84.

Median Age
At Death


U.S. 2010-2014, All Races, Both Sexes

Trends in RatesShow More

Changes Over Time

Keeping track of the number of new cases, deaths, and survival over time (trends) can help scientists understand whether progress is being made and where additional research is needed to address challenges, such as improving screening or finding better treatments.

Using statistical models for analysis, rates for new Hodgkin lymphoma cases have not changed significantly over the last 10 years. Death rates have been falling on average 3.7% each year over 2005-2014. 5-year survival trends are shown below the figure.

More About This CancerShow More

Hodgkin Lymphoma

Anatomy of the lymph system, showing the lymph vessels and lymph organs including lymph nodes, tonsils, thymus, spleen, and bone marrow. Lymph (clear fluid) and lymphocytes travel through the lymph vessels and into the lymph nodes where the lymphocytes destroy harmful substances. The lymph enters the blood through a large vein near the heart.
Figure: Lymph System
Click to enlarge.

Hodgkin lymphoma is a cancer of the immune system that is marked by the presence of a type of cell called the Reed-Sternberg cell. The two major types of Hodgkin lymphoma are classical Hodgkin lymphoma and nodular lymphocyte-predominant Hodgkin lymphoma. Symptoms include the painless enlargement of lymph nodes, spleen, or other immune tissue. Other symptoms include fever, weight loss, fatigue, or night sweats. Also called Hodgkin disease.

Additional Information

More Information

Here are some resources for learning more about Hodgkin lymphoma.


All statistics in this report are based on statistics from SEER and the Centers for Disease Control and Prevention's National Center for Health Statistics. Most can be found within:

Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2014, National Cancer Institute. Bethesda, MD,, based on November 2016 SEER data submission, posted to the SEER web site, April 2017.

Suggested Citation

All material in this report is in the public domain and may be reproduced or copied without permission; citation as to source, however, is appreciated.

SEER Cancer Stat Facts: Hodgkin Lymphoma. National Cancer Institute. Bethesda, MD,

These stat facts focus on population statistics that are based on the US population. Because these statistics are based on large groups of people, they cannot be used to predict exactly what will happen to an individual patient. To see tailored statistics, browse the SEER Cancer Statistics Review. To see statistics for a specific state, go to the State Cancer Profiles.

The statistics presented in these stat facts are based on the most recent data available, most of which can be found in the SEER Cancer Statistics Review. In some cases, different year spans may be used. Estimates for the current year are based on past data.

Cancer is a complex topic. There is a wide range of information available. These stat facts do not address causes, symptoms, diagnosis, treatment, follow-up care, or decision making, although links are provided to information in many of these areas.